A Single- and Multiple- Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2059 Powder for Inhalation
Clinical trial NCT07510958 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07510958
- Sponsor
- InnovStone Therapeutics Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-15
- Primary completion
- 2026-12-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.